
Startups & growth Analysis
Minutia develops insulin-producing cell transplants clinicians could monitor
Minutia is developing insulin-producing cell transplants with nanosensors that could help clinicians monitor whether the implanted cells survive.

MoneyMakers coverage
Page 1 of 1 · 1 report
Katy Digovich is Minutia’s CEO and co-founder.
Published reporting on Katy Digovich. Entries describe developments as reported on their publication dates.